衰弱与养老院过渡期潜在不适当用药使用
该回顾性队列研究纳入加拿大安大略省41351例66岁以上新入住养老院的认知障碍或痴呆患者,使用2015年Beers标准定义潜在不适当用药(PIM),发现入住时44%正在使用PIM且衰弱者比例更高,入住后衰弱者新起始苯二氮䓬类、抗精神病药和抗胆碱能药的风险更高。
要点
- 入住养老院时44%的认知障碍或痴呆患者正在使用PIM,衰弱者比例更高(48.1% vs 38.7%)。
- 入住后衰弱者新起始苯二氮䓬类(HR=1.32)、抗精神病药(HR=1.36)和抗胆碱能药(HR=1.34)风险更高。
- 应针对衰弱个体在养老院过渡期实施支持PIM减停的干预。
核心结论
- 许多认知障碍或痴呆患者在入住养老院时正在使用PIM,且衰弱个体在入住后更可能新起始PIM。
- 应针对衰弱个体在养老院过渡期实施支持PIM减停的干预。
研究设计与样本
- 回顾性队列研究,使用加拿大安大略省健康行政数据库。
- 纳入41351例66岁以上、2011至2014年新入住养老院的认知障碍或痴呆患者。
- PIM采用2015年Beers标准定义,包括抗精神病药、H2受体拮抗剂、苯二氮䓬类和强抗胆碱能药物。
- 使用多变量Cox比例风险模型评估衰弱状态(由72项衰弱指数确定)对起始和停用PIM风险的影响。
主要发现
- 入住时44%的居民正在使用PIM,患病率随衰弱程度变化:非衰弱38.7%、衰弱前期42.8%、衰弱48.1%(P < .001)。
- 入住后许多居民停用了PIM:抗精神病药23.5%、苯二氮䓬类49.3%、抗胆碱能药32.2%、H2受体拮抗剂30.9%。
- 入住后新起始PIM的比例:抗精神病药10.9%、苯二氮䓬类10.1%、抗胆碱能药6.6%、H2受体拮抗剂1.2%。
- 调整其他特征后,衰弱居民停用PIM的风险与非衰弱居民相似,但抗胆碱能药除外(HR = 1.21,95% CI 1.06-1.39)。
- 衰弱居民更可能新处方苯二氮䓬类(HR = 1.32,95% CI 1.20-1.44)、抗精神病药(HR = 1.36,95% CI 1.23-1.49)和抗胆碱能药(HR = 1.34,95% CI 1.20-1.50)。
关键数值与推荐
- PIM定义采用2015年Beers标准,包括抗精神病药、H2受体拮抗剂、苯二氮䓬类和强抗胆碱能药物。
- 衰弱状态由72项衰弱指数确定。
- 入住时PIM患病率:非衰弱38.7%、衰弱前期42.8%、衰弱48.1%(P < .001)。
- 衰弱者新起始苯二氮䓬类HR = 1.32(95% CI 1.20-1.44)、抗精神病药HR = 1.36(95% CI 1.23-1.49)、抗胆碱能药HR = 1.34(95% CI 1.20-1.50)。
临床怎么用
- 对认知障碍或痴呆患者入住养老院时应评估PIM使用情况,尤其关注衰弱个体。
- 在养老院过渡期针对衰弱个体实施支持PIM减停的干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/OBJECTIVES: To estimate the prevalence of potentially inappropriate medication (PIM) use among older adults with cognitive impairment or dementia prior to and following admission to nursing homes and in relation to frailty. DESIGN: Retrospective cohort study using health administrative databases. SETTING: Ontario, Canada. PARTICIPANTS: 41,351 individuals with cognitive impairment or dementia, aged 66+ years newly admitted to nursing home between 2011 and 2014. MEASUREMENTS: PIMs were defined with 2015 Beers Criteria and included antipsychotics, H2 -receptor antagonists, benzodiazepines, and drugs with strong anticholinergic properties. Medication information was obtained at nursing home admission and in the subsequent 180 days. Multivariable Cox proportional-hazards models were used to assess the impact of frailty status (determined by a 72-item frailty index) on the hazard of starting and discontinuing PIMs. RESULTS: At admission, 44% of residents with cognitive impairment or dementia were on a PIM and prevalence varied by frailty (38.7% non-frail, 42.8% pre-frail, and 48.1% frail, P < .001). Following admission, many residents discontinued PIMs (23.5% for antipsychotics, 49.3% benzodiazepines, 32.2% anticholinergics, and 30.9% H2 -receptor antagonists). However, PIMs were also introduced with 10.9% newly started on antipsychotics, benzodiazepines (10.1%), anticholinergics (6.6%), and H2 -receptor antagonists (1.2%). After adjustment for other characteristics, frail residents had a similar risk of PIM discontinuation as non-frail residents except for anticholinergics (HR = 1.21, 95% CI 1.06-1.39) but were more likely to be newly prescribed benzodiazepines (HR = 1.32, 95% CI 1.20-1.44), antipsychotics (HR = 1.36, 1.23-1.49), and anticholinergics (HR = 1.34, 95% CI 1.20-1.50). CONCLUSION: Many residents with cognitive impairment or dementia enter nursing homes on PIMs. PIMs are more likely to be started in frail individuals following admission. Interventions to support deprescribing of PIMs should be implemented targeting frail individuals during the transition to nursing home.
引用
- Maclagan LC, Maxwell CJ, Gandhi S, et al. Frailty and Potentially Inappropriate Medication Use at Nursing Home Transition. J Am Geriatr Soc. 2017. PMID: 28752589. doi:10.1111/jgs.15016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。